Preprint Article Version 1 This version is not peer-reviewed

Lactate to albumin ratio and mortality in patients with severe Coronavirus Disease-2019 admitted to intensive care unit

Version 1 : Received: 28 October 2024 / Approved: 28 October 2024 / Online: 28 October 2024 (14:05:13 CET)

How to cite: Routsi, C.; Kokkoris, S.; Gkoufa, A.; Katsaros, D.; Karageorgiou, S.; Kavalieratos, F.; Tsilivarakis, D.; Dimopoulou, G.; Theodorou, E.; Eleftheria, M.; Kotanidou, A.; Dimopoulou, I. Lactate to albumin ratio and mortality in patients with severe Coronavirus Disease-2019 admitted to intensive care unit. Preprints 2024, 2024102172. https://doi.org/10.20944/preprints202410.2172.v1 Routsi, C.; Kokkoris, S.; Gkoufa, A.; Katsaros, D.; Karageorgiou, S.; Kavalieratos, F.; Tsilivarakis, D.; Dimopoulou, G.; Theodorou, E.; Eleftheria, M.; Kotanidou, A.; Dimopoulou, I. Lactate to albumin ratio and mortality in patients with severe Coronavirus Disease-2019 admitted to intensive care unit. Preprints 2024, 2024102172. https://doi.org/10.20944/preprints202410.2172.v1

Abstract

Aim: This study sought to evaluate the effectiveness of lactate/albumin ratio for ICU mortality prediction in a large cohort of patients with severe Coronavirus Disease-2019 (COVID-19) admitted to the intensive care unit (ICU). Methods: This is a single-center retrospective cohort study of prospectively collected data derived from the COVID-19 dataset for all critically ill patients admitted to an academic ICU. Data were used to determine the relation between lactate/albumin ratio and other laboratory parameters measured on the first day of ICU stay and to evaluate the prognostic performance for ICU mortality prediction. Results: A total of 805 ICU patients were included, the median age (IQR) was 67 (57-76) years, with 68% being male. ICU mortality was 48% and the median lactate/albumin ratio was 0.53 (0.39-0.59). Survival analysis showed that patients with higher lactate/albumin ratio values had significantly lower survival rates (Log Rank p

Keywords

lactate, albumin, Covid-19, SARS-CoV-2, sepsis, outcome, ICU

Subject

Medicine and Pharmacology, Epidemiology and Infectious Diseases

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.